Cure My Disease

Don't miss your cure!

 Log in / Sign up

Do heart doctors know their own risk? a Congress-Wide Check-Up

NCT ID NCT07778784

Knowledge-focused Sponsor: European Society of Cardiology Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 21, 2026 · Last updated Aug 21, 2026

Summary

This study aims to screen cardiovascular risk among attendees of the ESC Congress 2026, focusing on healthcare professionals. Participants will undergo a capillary blood draw, urine sample, waist and blood pressure measurements, and answer a questionnaire about lifestyle and medical history. The goal is to assess objective risk scores and compare them with participants' self-perceived risk, potentially revealing gaps in awareness.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Cardiovascular risk screening including capillary blood draw, urine sample, questionnaire, and physical exam
What this could lead to
If successful, this could highlight gaps between perceived and actual cardiovascular risk among healthcare professionals, potentially informing future screening and prevention strategies.
What could go wrong
This is a cross-sectional study, so it cannot prove cause and effect. Results may not generalize beyond the specific congress attendees, and the screening methods may have limitations.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,300 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

A research network

The lead sponsor is a research network or cooperative group.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

All attendees including healthcare professionals (doctors, nurses, etc.) attending the ESC Congress 2026 from 28 to 31 August 2026

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All attendees including healthcare professionals (doctors, nurses, etc.) attending the ESC Congress 2026 from 28 to 31 August 2026 * Subjects who declare that they are able to understand and give informed consent in English * Adult subjects (≥ 18 years of age) Exclusion Criteria: * Subjects not willing to provide his/her consent to participate in the study. * Subjects who are not suitable candidates for blood extraction.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cardiovascular risks are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cardiovascular risks

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    The full official record for this study. This one lists no contact details, but it is the first place any would appear.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.